DARE
Price
$2.98
Change
+$0.08 (+2.76%)
Updated
Apr 30, 04:44 PM (EDT)
Capitalization
25.58M
NVCT
Price
$9.96
Change
-$0.37 (-3.58%)
Updated
Apr 30, 04:59 PM (EDT)
Capitalization
249.12M
13 days until earnings call
Ad is loading...

DARE vs NVCT

Header iconDARE vs NVCT Comparison
Open Charts DARE vs NVCTBanner chart's image
Dare Bioscience
Price$2.98
Change+$0.08 (+2.76%)
Volume$100
Capitalization25.58M
Nuvectis Pharma
Price$9.96
Change-$0.37 (-3.58%)
Volume$697
Capitalization249.12M
DARE vs NVCT Comparison Chart
Loading...
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DARE vs. NVCT commentary
Apr 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DARE is a Buy and NVCT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 30, 2025
Stock price -- (DARE: $2.90 vs. NVCT: $10.33)
Brand notoriety: DARE and NVCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DARE: 123% vs. NVCT: 275%
Market capitalization -- DARE: $25.58M vs. NVCT: $249.12M
DARE [@Biotechnology] is valued at $25.58M. NVCT’s [@Biotechnology] market capitalization is $249.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DARE’s FA Score shows that 0 FA rating(s) are green whileNVCT’s FA Score has 0 green FA rating(s).

  • DARE’s FA Score: 0 green, 5 red.
  • NVCT’s FA Score: 0 green, 5 red.
According to our system of comparison, NVCT is a better buy in the long-term than DARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DARE’s TA Score shows that 4 TA indicator(s) are bullish while NVCT’s TA Score has 4 bullish TA indicator(s).

  • DARE’s TA Score: 4 bullish, 4 bearish.
  • NVCT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both DARE and NVCT are a good buy in the short-term.

Price Growth

DARE (@Biotechnology) experienced а -2.19% price change this week, while NVCT (@Biotechnology) price change was +11.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.93%. For the same industry, the average monthly price growth was +3.53%, and the average quarterly price growth was -9.41%.

Reported Earning Dates

DARE is expected to report earnings on Mar 31, 2025.

NVCT is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+2.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVCT($249M) has a higher market cap than DARE($25.6M). NVCT YTD gains are higher at: 90.943 vs. DARE (-6.891). NVCT has higher annual earnings (EBITDA): -19.85M vs. DARE (-23.19M). NVCT has more cash in the bank: 18.5M vs. DARE (11.2M). DARE has higher revenues than NVCT: DARE (1.88M) vs NVCT (0).
DARENVCTDARE / NVCT
Capitalization25.6M249M10%
EBITDA-23.19M-19.85M117%
Gain YTD-6.89190.943-8%
P/E Ratio0.10N/A-
Revenue1.88M0-
Total Cash11.2M18.5M61%
Total Debt1.4MN/A-
FUNDAMENTALS RATINGS
DARE: Fundamental Ratings
DARE
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
74
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DARENVCT
RSI
ODDS (%)
N/A
Bearish Trend 7 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 22 days ago
76%
Bullish Trend 7 days ago
88%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AQN5.370.02
+0.37%
Algonquin Power & Utilities Corp
DFS185.37-0.13
-0.07%
Discover Financial Services
FBRT11.59-0.05
-0.43%
Franklin BSP Realty Trust
AFCG5.32-0.12
-2.21%
Advanced Flower Capital Inc
OVID0.34-0.01
-3.34%
Ovid Therapeutics

DARE and

Correlation & Price change

A.I.dvisor indicates that over the last year, DARE has been closely correlated with AZTR. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if DARE jumps, then AZTR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DARE
1D Price
Change %
DARE100%
+0.52%
AZTR - DARE
73%
Closely correlated
+3.33%
CYTK - DARE
42%
Loosely correlated
+0.17%
AXON - DARE
39%
Loosely correlated
+1.44%
GTBP - DARE
38%
Loosely correlated
N/A
AMRN - DARE
34%
Loosely correlated
+0.10%
More

NVCT and

Correlation & Price change

A.I.dvisor tells us that NVCT and DARE have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVCT and DARE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCT
1D Price
Change %
NVCT100%
-3.00%
DARE - NVCT
30%
Poorly correlated
+0.52%
SGMT - NVCT
29%
Poorly correlated
+3.32%
UTHR - NVCT
29%
Poorly correlated
+1.25%
PDSB - NVCT
28%
Poorly correlated
+1.61%
FTRE - NVCT
28%
Poorly correlated
+4.11%
More